Literature DB >> 11025635

Mycotic aneurysm on posterior cerebral artery: resolution with medical therapy.

A K Meena1, S Sitajayalakshmi, V S Prasad, J M Murthy.   

Abstract

Mycotic aneurysms on the branches of vertebro basilar artery are rare. A patient of infective endocarditis with mycotic aneurysm on the posterior cerebral artery is described. The aneurysm resolved with medical therapy. Controversies regarding the management of mycotic aneurysms are discussed.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11025635

Source DB:  PubMed          Journal:  Neurol India        ISSN： 0028-3886            Impact factor:   2.117


  6 in total

1.  Treatment strategy for aneurysms of the posterior cerebral artery.

Authors:  O Suzuki; S Miyachi; M Negoro; T Okamoto; Y Sahara; K Hattori; N Kobayashi; T Kojima; J Yoshida
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

2.  Mycotic aneurysm: an uncommon cause for intra-cranial hemorrhage.

Authors:  Sandip Bartakke; Ujjwala Kabde; Mamta N Muranjan; S B Bavdekar
Journal:  Indian J Pediatr       Date:  2002-10       Impact factor: 1.967

3.  Current treatment of active infective endocarditis with brain complications.

Authors:  Takashi Miura; Kiyoyuki Eishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-04-05

Review 4.  HydroCoil embolization of a ruptured infectious aneurysm in a pediatric patient: case report and review of the literature.

Authors:  Christopher Eddleman; Dimitrios Nikas; Ali Shaibani; Pervez Khan; Arthur J Dipatri; Tadanori Tomita
Journal:  Childs Nerv Syst       Date:  2006-12-23       Impact factor: 1.532

5.  Ruptured mycotic cerebral aneurysm development from pseudoocclusion due to septic embolism.

Authors:  Grant C Sorkin; Naser Jaleel; Maxim Mokin; Travis M Dumont; Jorge L Eller; Adnan H Siddiqui
Journal:  Surg Neurol Int       Date:  2013-11-08

Review 6.  Endovascular Treatment of Posterior Cerebral Artery Trunk Aneurysm: The Status Quo and Dilemma.

Authors:  Kun Hou; Xianli Lv; Jinlu Yu
Journal:  Front Neurol       Date:  2022-01-06       Impact factor: 4.003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.